Clinical Trial Update: EXercise Influence on Taxane Side Effects (EXIT) Study [NA]

View source ↗

Summary

The EXIT study evaluating whether structured exercise influences taxane-related side effects in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of British Columbia | Conditions: Breast Neoplasms | NA | Status: COMPLETED